Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

Presenilin 1 (PS1) is required for the proteolytic processing of Notch and the β-amyloid precursor protein (APP), molecules that play pivotal roles in cell-fate determination during development and Alzheimer's disease pathogenesis, respectively. In addition, PS1 interacts with β-catenin and promotes its turnover through independent mechanisms. Consistent with this activity, we report here that PS1 is important in controlling epidermal cell proliferation in vivo . PS1 knockout mice that are rescued through neuronal expression of human PS1 transgene develop spontaneous skin cancers. PS1-null keratinocytes exhibit higher cytosolic β-catenin and β-catenin/lymphoid enhancer factor-1/T cell factor (β-catenin/LEF)-mediated signaling. This effect can be reversed by reintroducing wild-type PS1, but not a PS1 mutant active in Notch processing but defective in β-catenin binding. Nuclear β-catenin protein can be detected in tumors. Elevated β-catenin/LEF signaling is correlated with activation of its downstream target cyclin D1 and accelerated entry from G 1 into S phase of the cell cycle. This report demonstrates a function of PS1 in adult tissues, and our analysis suggests that deregulation of β-catenin pathway contributes to the skin tumor phenotype.

Bibliography

Xia, X., Qian, S., Soriano, S., Wu, Y., Fletcher, A. M., Wang, X.-J., Koo, E. H., Wu, X., & Zheng, H. (2001). Loss of presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis. Proceedings of the National Academy of Sciences, 98(19), 10863–10868.

Authors 9
  1. Xuefeng Xia (first)
  2. Su Qian (additional)
  3. Salvador Soriano (additional)
  4. Ying Wu (additional)
  5. Anthony M. Fletcher (additional)
  6. Xiao-Jing Wang (additional)
  7. Edward H. Koo (additional)
  8. Xiangwei Wu (additional)
  9. Hui Zheng (additional)
References 48 Referenced 196
  1. 10.1038/375754a0
  2. 10.1016/S0962-8924(98)01363-4
  3. 10.1074/jbc.272.6.3590
  4. 10.1083/jcb.147.2.277
  5. 10.1016/S1097-2765(00)80219-1
  6. 10.1016/S0896-6273(00)80291-3
  7. 10.1038/34910
  8. 10.1038/19083
  9. 10.1016/S0092-8674(00)80675-3
  10. 10.1016/S0092-8674(00)80244-5
  11. 10.1038/387288a0
  12. 10.1038/19091
  13. 10.1038/19096
  14. 10.1016/S0896-6273(00)80999-X
  15. 10.1097/00001756-199705260-00054
  16. 10.1016/S0014-5793(98)00886-2
  17. 10.1074/jbc.273.26.16470
  18. 10.1016/S0959-437X(98)80068-3
  19. 10.1093/emboj/18.9.2401
  20. 10.1038/382638a0
  21. 10.1126/science.281.5382.1509
  22. 10.1073/pnas.96.10.5522
  23. 10.1038/18884
  24. 10.1038/73448
  25. 10.1126/science.275.5307.1787
  26. 10.1016/S0092-8674(00)81631-1
  27. 10.1038/7747
  28. 10.1038/27208
  29. 10.1523/JNEUROSCI.19-11-04229.1999
  30. 10.1083/jcb.152.4.785
  31. 10.1097/00125480-199809000-00001
  32. 10.1016/0092-8674(87)90498-3
  33. 10.1074/jbc.M909624199
  34. 10.1126/science.275.5307.1784
  35. 10.1101/gad.7.5.812
  36. R G Pestell, C Albanese, A T Reutens, J E Segall, R J Lee, A Arnold Endocr Rev 20, 501–534 (1999). / Endocr Rev by Pestell R G (1999)
  37. 10.1093/genetics/155.4.1725
  38. 10.1006/dbio.2000.9925
  39. 10.1073/pnas.060025397
  40. A B Bianchi, S M Fischer, A I Robles, E M Rinchik, C J Conti Oncogene 8, 1127–1133 (1993). / Oncogene by Bianchi A B (1993)
  41. 10.1093/carcin/16.4.781
  42. 10.1101/gad.12.16.2469
  43. M L Rodriguez-Puebla, M LaCava, C J Conti Cell Growth Differ 10, 467–472 (1999). / Cell Growth Differ by Rodriguez-Puebla M L (1999)
  44. 10.1073/pnas.041603398
  45. 10.1073/pnas.98.1.229
  46. 10.1126/science.271.5257.1826
  47. 10.1128/jvi.66.4.2594-2599.1992
  48. 10.1084/jem.183.5.2283
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:37 a.m.)
Deposited 3 years, 4 months ago (April 13, 2022, 5:35 a.m.)
Indexed 1 month, 1 week ago (July 20, 2025, 6:54 p.m.)
Issued 24 years ago (Aug. 21, 2001)
Published 24 years ago (Aug. 21, 2001)
Published Online 24 years ago (Aug. 21, 2001)
Published Print 23 years, 11 months ago (Sept. 11, 2001)
Funders 0

None

@article{Xia_2001, title={Loss of presenilin 1 is associated with enhanced β-catenin signaling and skin tumorigenesis}, volume={98}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.191284198}, DOI={10.1073/pnas.191284198}, number={19}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Xia, Xuefeng and Qian, Su and Soriano, Salvador and Wu, Ying and Fletcher, Anthony M. and Wang, Xiao-Jing and Koo, Edward H. and Wu, Xiangwei and Zheng, Hui}, year={2001}, month=aug, pages={10863–10868} }